Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Gastrointestinal Therapeutics Market to reach USD 58.36 billion by the end of 2030

Global Gastrointestinal Therapeutics Market Size Study & Forecast, by Drug Class (Biologics, Proton Pump Inhibitors, Aminosalicylates, Antacids, Laxatives, H2 Antagonists, Others), by Application (Inflammatory Bowel Disease, Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Irritable Bowel Syndrome, Others), by Distribution Channel and Regional Analysis, 2023-2030

Product Code: HLSDT-21366437
Publish Date: 15-11-2023
Page: 200

Global Gastrointestinal Therapeutics Market is valued at approximately USD 39.5 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5% over the forecast period 2023-2030. Gastrointestinal therapeutics is a specific area of medicine that aims to identify and manage disorders that affect the gastrointestinal tract. It is primarily concerned with treating issues that affect the organs within the gastrointestinal system, such as the stomach, small intestine, large intestine, and rectum. It involves various interventions, including medications that aim to alleviate symptoms, improve the overall function of the gastrointestinal system, and enhance the quality of life for individuals affected by these conditions. The market for these treatments is driven by factors such as an increase in the incidence of gastrointestinal disorders, a growing geriatric population, and the launch of new products by key companies. However, the market growth is hindered by strict government regulations regarding the approval of biosimilars and the expiration of drug patents during the forecast period of 2023-2030.

The growth of the gastrointestinal therapeutics market is being fueled by a surge in the prevalence of gastrointestinal diseases such as Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), and gastrointestinal cancers. According to an article published by the National Stem Cell Foundation, in 2023, over 80 different autoimmune diseases affect nearly 4% of the world population, with the most common being type 1 diabetes, rheumatoid arthritis, lupus, Crohn’s disease, multiple sclerosis , scleroderma, and psoriasis. Additionally, the increase in elderly individuals who are more susceptible to gastrointestinal conditions has led to a rise in demand for gastrointestinal therapeutics. According to an article published by the National Center for Biotechnology and Information (NCBI) in 2023, which reported that the burden of inflammatory bowel disease (IBD) is increasing worldwide, with a particular increase in prevalence in the elderly population. Furthermore, patients increased awareness of gastrointestinal disorders and available treatments has led to higher diagnosis rates and increased demand for therapeutics, contributing to market growth. Advances in pharmaceutical research and development have also led to the discovery of new drugs, novel delivery systems, and targeted therapies, providing opportunities for the market. Precision medicine, biologics, and personalized treatment approaches are expanding the treatment options available for various gastrointestinal conditions. For example, in June 2023, AbbVie Inc. announced positive top-line results from its Phase 3 maintenance study, COMMAND, showing Risankizumab (SKYRIZI) achieved the primary endpoint of clinical remission at week 52, as well as key secondary endpoints in adult patients with moderately to severely active ulcerative colitis.

The key regions considered for the Global Gastrointestinal Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. In 2022, North America was the dominant market for gastrointestinal therapeutics due to the presence of several major players in the region. The well-established healthcare infrastructure, high purchasing power, and increased adoption of gastrointestinal therapeutics also contributed to the market’s growth. Additionally, key players in the region launched new products and obtained product approvals, further boosting market growth. Asia Pacific is expected to experience significant growth over the forecast period due to factors such as changing dietary habits, urbanization, lifestyle shifts, and an aging population leading to a rise in the prevalence of gastrointestinal disorders.

Major market player included in this report are:
Bristol-Myers Squibb Company
AbbVie Inc.
Pfizer Inc.
AstraZeneca plc
Bayer AG
Takeda Pharmaceutical Company Limited
Organon Group of Companies
Bausch Health Companies Inc.
Cosmo Pharmaceuticals N.V.
Teva Pharmaceutical Industries Limited

Recent Developments in the Market:
Ø In May 2023, AbbVie announced that RINVOQ has been approved by the U.S. Food and Drug Administration (FDA) to treat adults with moderately to severely active Crohn’s disease who have not responded well to one or more TNF blockers, or cannot tolerate them. Additionally, in April 2023, AbbVie reported that RINVOQ has also been approved by the European Commission (EC) as the first oral Janus Kinase (JAK) inhibitor to treat adult patients with moderately to severely active Crohn’s disease.
Ø In May 2021, Bristol Myers Squibb made an announcement that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 mg to treat adults with moderately to severely active ulcerative colitis (UC), which is a chronic Inflammatory Bowel Disease (IBD).
Ø In January 2021, AstraZeneca, and Daiichi Sankyo Company, Limited announced the U.S. approval for Enhertu to treat HER2-positive Gastric or Gastroesophageal Junction (GEJ) adenocarcinoma in adults who have received a previous trastuzumab-based regimen.
Global Gastrointestinal Therapeutics Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Drug Class, Application, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:
Proton Pump Inhibitors
H2 Antagonists

By Application:
Inflammatory Bowel Disease
Gastroesophageal Reflux Disease
Peptic Ulcer Disease
Irritable Bowel Syndrome

By Distribution Channel:
Hospitals Pharmacies
Drug Stores
Retail Pharmacies
Online Providers

By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Gastrointestinal Therapeutics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Gastrointestinal Therapeutics Market, by Drug Class, 2020-2030 (USD Billion)
1.2.3. Gastrointestinal Therapeutics Market, by Application, 2020-2030 (USD Billion)
1.2.4. Gastrointestinal Therapeutics Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Gastrointestinal Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Gastrointestinal Therapeutics Market Dynamics
3.1. Gastrointestinal Therapeutics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Increase in prevalence of gastrointestinal diseases Rise in geriatric population Rise in the number of product launches
3.1.2. Market Challenges Stringent government regulations toward approval of biosimilars Expiration of the drugs patent
3.1.3. Market Opportunities Rise in Research & Development activities Growth opportunities in emerging markets
Chapter 4. Global Gastrointestinal Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Gastrointestinal Therapeutics Market, by Drug Class
5.1. Market Snapshot
5.2. Global Gastrointestinal Therapeutics Market by Drug Class, Performance – Potential Analysis
5.3. Global Gastrointestinal Therapeutics Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Gastrointestinal Therapeutics Market, Sub Segment Analysis
5.4.1. Biologics
5.4.2. Proton Pump Inhibitors
5.4.3. Aminosalicylates
5.4.4. Antacids
5.4.5. Laxatives
5.4.6. H2 Antagonists
5.4.7. Others
Chapter 6. Global Gastrointestinal Therapeutics Market, by Application
6.1. Market Snapshot
6.2. Global Gastrointestinal Therapeutics Market by Application, Performance – Potential Analysis
6.3. Global Gastrointestinal Therapeutics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Gastrointestinal Therapeutics Market, Sub Segment Analysis
6.4.1. Inflammatory Bowel Disease
6.4.2. Gastroesophageal Reflux Disease
6.4.3. Peptic Ulcer Disease
6.4.4. Irritable Bowel Syndrome
6.4.5. Others
Chapter 7. Global Gastrointestinal Therapeutics Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Gastrointestinal Therapeutics Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Gastrointestinal Therapeutics Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Gastrointestinal Therapeutics Market, Sub Segment Analysis
7.4.1. Hospitals Pharmacies
7.4.2. Drug Stores
7.4.3. Retail Pharmacies
7.4.4. Online Providers
Chapter 8. Global Gastrointestinal Therapeutics Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Gastrointestinal Therapeutics Market, Regional Market Snapshot
8.4. North America Gastrointestinal Therapeutics Market
8.4.1. U.S. Gastrointestinal Therapeutics Market Drug Class breakdown estimates & forecasts, 2020-2030 Application breakdown estimates & forecasts, 2020-2030 Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Gastrointestinal Therapeutics Market
8.5. Europe Gastrointestinal Therapeutics Market Snapshot
8.5.1. U.K. Gastrointestinal Therapeutics Market
8.5.2. Germany Gastrointestinal Therapeutics Market
8.5.3. France Gastrointestinal Therapeutics Market
8.5.4. Spain Gastrointestinal Therapeutics Market
8.5.5. Italy Gastrointestinal Therapeutics Market
8.5.6. Rest of Europe Gastrointestinal Therapeutics Market
8.6. Asia-Pacific Gastrointestinal Therapeutics Market Snapshot
8.6.1. China Gastrointestinal Therapeutics Market
8.6.2. India Gastrointestinal Therapeutics Market
8.6.3. Japan Gastrointestinal Therapeutics Market
8.6.4. Australia Gastrointestinal Therapeutics Market
8.6.5. South Korea Gastrointestinal Therapeutics Market
8.6.6. Rest of Asia Pacific Gastrointestinal Therapeutics Market
8.7. Latin America Gastrointestinal Therapeutics Market Snapshot
8.7.1. Brazil Gastrointestinal Therapeutics Market
8.7.2. Mexico Gastrointestinal Therapeutics Market
8.8. Middle East & Africa Gastrointestinal Therapeutics Market
8.8.1. Saudi Arabia Gastrointestinal Therapeutics Market
8.8.2. South Africa Gastrointestinal Therapeutics Market
8.8.3. Rest of Middle East & Africa Gastrointestinal Therapeutics Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Bristol-Myers Squibb Company Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
9.3.2. AbbVie Inc.
9.3.3. Pfizer Inc.
9.3.4. AstraZeneca plc
9.3.5. Bayer AG
9.3.6. Takeda Pharmaceutical Company Limited
9.3.7. Organon Group of Companies
9.3.8. Bausch Health Companies Inc.
9.3.9. Cosmo Pharmaceuticals N.V.
9.3.10. Teva Pharmaceutical Industries Limited
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now